期刊文献+

尿毒症脑病腹膜透析前后神经胶质纤维酸性蛋白变化与影像学评价 被引量:4

Change of glial fibers acidic protein and the imaging evaluation in the patients with uremic encephalopathy before and after peritoneal dialysis
暂未订购
导出
摘要 目的 通过检测腹膜透析前后血清神经胶质纤维酸性蛋白(glial fibrillary acidic potein,GFAP)水平的变化联合头颅磁共振(MRI)影像学比较评估腹膜透析治疗尿毒症脑病(uremic encephalopathy,UE)的疗效和预后.方法 将未进行过透析治疗的慢性肾功能衰竭(chronic renalfailure,CRF)患者按有无中枢神经系统异常分为UE组和尿毒症对照组,并选择来自同期门诊健康体检的人群作为健康对照组.UE组和尿毒症对照组在腹膜透析治疗前及治疗后1周、2周、4周分别测定血清GFAP水平和行头颅MRI检查.结果 治疗前,UE组血清GFAP水平高于尿毒症对照组和健康对照组(均P<0.01);UE组中检出MRI异常信号灶的患者占18/38(47.4%),尿毒症对照组中检出MRI异常信号灶的患者占2/40(5%),2组比较差异具有统计学意义(P<0.01).随着腹膜透析的进行,UE组血清GFAP水平逐渐下降,头颅MRI异常信号逐渐减轻.至治疗后4周,UE组血清GFAP水平基本降至正常水平,大部分患者中枢神经系统损害的症状完全消失,仅有5例患者遗留有轻度的认知功能减退,5例中其中4例(占10.5%)患者遗留有长T1长T2信号.结论 血清GFAP水平联合头颅MRI影像学比较可以作为临床上评估UE患者神经系统损害程度及透析治疗的疗效和预后的有效手段之一. Objective To evaluate the curative effect and prognosis of peritoneal dialysis in the patients with uremic encephalopathy (UE) by detecting the change of serum glial fibrillary acidic po- tein (GFAP) level and MRI imaging of head before and after peritoneal dialysis. Methods The pa- tients with chronic renal failure without dialysis were divided into UE group and uremia control group. The health check-up volunteers served as healthy control group. In UE group and uremia control group serum level of GFAP was determined and head MRI examination was done before and on the 1st, 2nd and 4th week after peritoneal dialysis. Results Before treatment, the serum GFAP level in UE group was higher than in uremia control group and healthy control group (P0. 01). There were 18 cases of abnormal MRI signal detection in UE group (18/38, 47. 40/oo), and 2 cases in uremia con- trol group (2/40, 5 %). With peritoneal dialysis, the level of serum GFAP was gradually declined and the abnormal MRI signal gradually reduced. At 4th week after treatment, the serum GFAP level in UE group was nearly normal and the damage symptoms of central nervous system disappeared in the majority of patients of UE group. Only 5 patients had mild cognitive decline, including four of five pa- tients (10. 5%) with long Tl-long T2 signals. Conclusions The changes of serum GFAP level com- bined with MRI imaging of head could be used effectively as a clinical assessment of nerve damage de-gree, the curative effect and prognosis of dialysis in UE.
出处 《临床肾脏病杂志》 2014年第2期90-93,共4页 Journal Of Clinical Nephrology
基金 广西自然基金资助项目(NQ2012JJAA40611)
关键词 尿毒症脑病 腹膜透析 神经胶质纤维酸性蛋白 核磁共振 Uremia encephalopathy Peritoneal dialysis Glial fihrillary acidic potein Magnetic resonance imaging
  • 相关文献

参考文献13

  • 1Jessen KR, Thorpe R, Mirsky R. Molecular identity, distribu- tion and heterogeneity of glial fibrillary acidic protein: An im- munoblotting and immunohistochemical study of Schwann cells,satellite cells, enteric glia and astrocytes. J Neurocytol, 1984,13: 187-200.
  • 2Ehlers S, Kyllerman M, Rosengren L. Analysis of glial fibrillar- y acidic protein in the cerebrospinal fluid of children investiga- ted for encephalopathy. Neuropediatrics, 1994,25 : 129-133.
  • 3Herrmann M, Vos P, Wunderlich MT, et al. Release of glial tis- sue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary a- cidic protein. Stroke, 2000,31 : 2670-2677.
  • 4王海燕 主编.肾脏病学第2版[M].北京:人民卫生出版社,1998.556—566.
  • 5Fraser DD, Close TE, Rose KL, et al. Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cere- brospinal fluid and serum, l~ediatr Crit Care Med, 2011,12: 319-324.
  • 6Nyl6n K,Ost M,Csajbok LZ, et al. Increased serum-GFAP in patients with severe traumatic brain injury is related to out- come. J Neurol Sci,2006,240:85-91.
  • 7De Deyn PP, Vanholder R, Eloot S, et al. Guanidino compounds as uremic (neuto) toxins. Semin Dial, 2009,22 : 340-345.
  • 8Hosoya K, Tachikawa M. Roles of organic anion/cation trans- porters at the blood-brain and blood-cerebrospinal fluid barri- ers involving uremic toxins. Clin Exp Nephrol, 2011,15: 478- 485.
  • 9Heidland A, Sebekova K, Klassen A, et al. Mechanisms of a- cute uremic encephalopathy: Early activation of Fos and Fra-2 gene products in different nuclei/areas of the rat brain. J Ren Nutr, 2010,20:S44-50.
  • 10李明子,张旭,王继伟,孙华,朱白.氨基酸腹膜透析液治疗尿毒症脑病的临床观察[J].中国老年学杂志,2011,31(17):3400-3401. 被引量:3

二级参考文献4

  • 1Oreopoulos DG, Crassweller P, Katirtzoglou A,et al. Amino acids as an osmotic agent( instead of glucose)in continuous ambulatory peritoneal di- alysis. In: Legrain M, ed. Proceedings of an internalional symposium [M]. Amsterdam : Excerpta Medica, 1979 : 355-40.
  • 2Kopple JD, Bernard D, Messana J,et al. Treatment of malnourished CAPD patients with an amino acid based dialysate [J]. Kidney Int, 1995 ;47 (4) :1148-57.
  • 3王海燕.肾脏病学[M]第2版[M].北京:人民卫生出版社,1998.103-104.
  • 4侯凡凡.对尿毒症毒素的新认识[J].中华肾脏病杂志,2003,19(2):69-70. 被引量:65

共引文献16

同被引文献31

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部